Series date: 
01/01/2023 - 6:00am CST to 12/31/2023 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to:   (1) Identify the appropriate NCCN and ASH guidelines, (2) Recognize common presenting symptoms and understand treatment modalities for patients with leukemia.  (3) Analyze clinical trials available for leukemic patients through the Baylor Research Institute.

PLANNER/MODERATOR DISCLOSURE:  Charles Buess, MD, has no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Taylor Martinez at [email protected]

 

 

Series location: 
Baylor Charles A. Sammons Cancer Center - Dallas Campus
3410 Worth Street Ste 580
Dallas, TX 75246
United States

Sessions

Session Date
20230315 Dallas Hematology/Oncology Disease TB 03/15/2023 - 12:30pm to 1:30pm CDT
20230322 Dallas Hematology/Oncology Disease TB 03/22/2023 - 12:30pm to 1:30pm CDT
CANCELLED - 20230329 Dallas Hematology/Oncology Disease TB 03/29/2023 - 12:30pm to 1:30pm CDT
20230405 Dallas Hematology/Oncology Disease TB 04/05/2023 - 12:30pm to 1:30pm CDT
20230412 Dallas Hematology/Oncology Disease TB 04/12/2023 - 12:30pm to 1:30pm CDT
20230419 Dallas Hematology/Oncology Disease TB 04/19/2023 - 12:30pm to 1:30pm CDT
20230426 Dallas Hematology/Oncology Disease TB 04/26/2023 - 12:30pm to 1:30pm CDT
20230503 Dallas Hematology/Oncology Disease TB 05/03/2023 - 12:30pm to 1:30pm CDT
20230510 Dallas Hematology/Oncology Disease TB 05/10/2023 - 12:30pm to 1:30pm CDT
20230517 Dallas Hematology/Oncology Disease TB 05/17/2023 - 12:30pm to 1:30pm CDT

Pages